Integer Holdings Corporation (ITGR) Price Prediction 2026–2050

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies.

In addition, the company provides rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets.

The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.

Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Integer Holdings Corporation is a healthcare company traded as ITGR with a current price of $90.96 and a market capitalization of $3.09B. It holds a rank of 1731 among listed assets and operates within the Healthcare category. The outlook from the forecast shows a rising trajectory in average prices over time, with near-term stability and meaningful upside potential in the outer years.

The company’s branding includes the Greatbatch Medical and Lake Region Medical labels, reflecting its legacy in the medical device space.

The year-by-year forecast shows a path of rising averages and upside across the horizon. For 2026, the avg is $90.96 with a min of $76.78 and a max of $116.22, and ROI of 0 with neutral sentiment. In 2027 the avg is $106.88, the max is $136.66 and the min is $87.44, with ROI of 17.5 and neutral sentiment.

The 2028 forecast lists an avg of $118.89 and a max of $156.07 (min $95.49, ROI 30.7, sentiment bullish). In 2029 the avg is $133.13 with a max of $178.44 (min $105.31, ROI 46.4, sentiment bullish). By 2030 the avg rises to $171.03, with a min of $133.51 and a max of $233.35, and ROI of 88 with bullish sentiment.

The trajectory continues through 2031 (avg $188.04, max $260.58, min $145.02, ROI 106.7, bullish), 2032 (avg $189.45, max $266.25, min $144.48, ROI 108.3, bullish), 2033 (avg $210.76, max $300.02, min $159.07, ROI 131.7, bullish), 2034 (avg $221.79, max $319.47, min $165.75, ROI 143.8, bullish), and 2035 (avg $248.42, max $361.80, min $183.91, ROI 173.1, bullish). Long-range forecasts extend to 2040 (avg $358.11, max $546.49, min $254.20, ROI 293.7, bullish) and 2050 (avg $787.72, max $1,288.39, min $521.41, ROI 766, bullish). These figures point to a sustained bullish tilt, with higher downside risk and volatility inherent to long-horizon projections.

These are estimates and not guarantees of future performance.